Related Experiment Video
Updated: May 6, 2026

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
Published on: December 27, 2013
Simulation of Drug Release from PLGA Particles In Vivo
Kaori Sasaki1, Martha Igarashi, Manami Hinata
1Laboratory of Gastrointestinal Tract Reconstruction, Tohoku University, Graduate School of Biomedical Engineering, Japan.
Abstract:
Specific targeting of tissues and/or cells is essential for any type of drug delivery system because this determines the efficacy and side effects of the drug. Poly lactic-co-glycolic acids (PLGA) have long been used as biomaterials for drug delivery due to their excellent biocompatibility and biodegradability. Direct visualization of PLGA particles is feasible even within tissues, and cell specificity of the drug delivery system is normally assessed by using labeled particles. However, particle labeling alone does not address factors such as the release and distribution of the drug. Thus, it is desirable to set up a simulation system of drug release and distribution in vivo. In the present study, we aimed to establish a method to simulate drug distribution in PLGA drug delivery by using Hoechst 33342 as an imitating drug. Our approach enabled us to identify, isolate, and characterize cells exposed to Hoechst 33342 and to deduce the concentration of this fluorescent dye around both targeted and nontargeted cells. We believe that the method described herein will provide essential information regarding the specificity of cell targeting in any type of PLGA drug delivery system.
Related Concept Videos
Modified-Release Drug Delivery Systems: Bioavailability
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Drug Release Characteristics
In Vitro Drug Release Testing: Overview, Development and Validation
Modified-Release Drug Delivery Systems: Rate-Programmed I
In Vitro Drug Dissolution: Compendial Testing Models II

